Adherence to oral hormonal therapy in advanced prostate cancer: a scoping review.
Neil E FleshnerShabbir M H AlibhaiKim A ConnellyIlidio MartinsBernhard J EiglHimu LukkaArmen AprikianPublished in: Therapeutic advances in medical oncology (2023)
Oral hormonal therapy plays an important role in the treatment of advanced prostate cancer. Data on adherence to oral hormonal therapies in prostate cancer were generally of low quality, with high heterogeneity and inconsistent reporting across studies. Short study follow-up for adherence and focus on medication possession rates may further limit relevance of available data, especially in settings that require long-term treatment. Additional research is required to comprehensively assess adherence.